Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo's Melanoma Drugs Gets FDA Priority Review
Glaxo's Melanoma Drugs Gets FDA Priority Review
Glaxo's Melanoma Drugs Gets FDA Priority Review
Submitted by
admin
on September 16, 2013 - 5:49pm
Source:
PharmaLive
News Tags:
melanoma
GSK
FDA
Tafinlar
Mekinist
trametinib
dabrafenib
metastatic melanoma
Headline:
Glaxo's Melanoma Drugs Gets FDA Priority Review
Do Not Allow Advertisers to Use My Personal information
